<i>CYP2C19</i> Genotype Prevalence and Association With Recurrent Myocardial Infarction in British-South Asians Treated With Clopidogrel.

导出 LinkOut

翻译打印收藏纠错

第一作者： Emma F,Magavern

第一单位： William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

作者： Emma F,Magavern ^[1] ; Benjamin,Jacobs ^[2] ; Helen,Warren ^[1] ; Gherardo,Finocchiaro ^[3] ; Sarah,Finer ^[4] ; David A,van Heel ^[2] ; Genes & Health Research Team ^[1] ; Damian,Smedley ^[1] ; Mark J,Caulfield

作者单位： William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. ^[1] The Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom. ^[2] Cardiovascular Sciences Research Centre, St George's, University of London, London, United Kingdom. ^[3] The Blizard Institute, Queen Mary University of London, London, United Kingdom. ^[4]

关键词 ischemic heart disease pharmacogenomics pharmacotherapy preventive cardiology

DOI 10.1016/j.jacadv.2023.100573

PMID 37808344

发布时间 2024-06-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JACC. Advances

2023年2卷7期

None页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

<i>CYP2C19</i> Genotype Prevalence and Association With Recurrent Myocardial Infarction in British-South Asians Treated With Clopidogrel.

JACC. Advances

相似文献

JACC. Advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

<i>CYP2C19</i> Genotype Prevalence and Association With Recurrent Myocardial Infarction in British-South Asians Treated With Clopidogrel.

JACC. Advances

相似文献

JACC. Advances

相关期刊

检索历史清除